Keywords = PD-L1
Number of Articles: 15
Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin Lymphoma as Prognostic Factor

Volume 24, Issue 8, August 2023, Pages 2829-2835

Behnaz Bouzari; Ali Basi; Shadi Dadkhah; Mahshid Panahi; Soha Mohammadi

Expression of Programmed Death Ligand1 (PD-L1) in Gastric Carcinoma (Histopathological and Immunohistochemical Study)

Volume 24, Issue 7, July 2023, Pages 2295-2303

Safa Mohammed Ali; Dina Omar Helmy; Hanan Soliman Abdelhamid; Mona Salah Eldin Abdelmagid Mahmoud

Programmed Death Ligand -1 and Gene Mutation Characterization of Lung Malignancies in Patients at a Rural Hospital in Central India

Volume 24, Issue 6, June 2023, Pages 1855-1861

Mala Kanthali; Pragati Mamgain; Piyush Dhawan; Gautam Bhagwat; Swati Patel; Manju Raj Purohit

Analysis of PD-L1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis in Asian Population

Volume 24, Issue 5, May 2023, Pages 1453-1462

Putu Anda Tusta Adiputra; I Wayan Sudarsa; Desak Made Wihandani; I Putu Gede Septiawan Saputra; Sinta Wiranata; I Gede Putu Supadmanaba

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma

Volume 23, Issue 12, December 2022, Pages 4333-4338

Amal Ahmed Hareedy; El Zahraa Ahmed Rohim; Samar Abdel Monem Al Sheikh; Zeinab Abd El Azeem Al Shereef

PD-L1 and the Clinical Outcomes of Ovarian Cancer: Meta-Analysis and Bioinformatical Analysis

Volume 23, Issue 7, July 2022, Pages 2285-2290

Xiaoling Shi; Liu Yun; Liu Chaoqun Liu; Hui Ding; Dan Liang; Fang Geng; Hainan Yu; Jinxiu Ban; Jiajing Li; Tao Jiang; Yi Sun

Expression of PD-L1 in Locally Advanced Breast Cancer and Its Impact on Neoadjuvant Chemotherapy Response

Volume 23, Issue 6, June 2022, Pages 2095-2103

Mustafa A Hussein; Hoda Abdel-Raouf Ismail; Mona Sakr; Mohamed Akram Nouh

Expression of PD-L1 in Early-Stage Invasive Breast Carcinoma and Its Relation to Tumor-Infiltrating Lymphocytes

Volume 23, Issue 3, March 2022, Pages 1091-1102

Nancy H Amin; Amany A Abou-Bakr; Saad Eissa; Hanan R Nassar; Tamer S Eissa; Ghada Mohamed

NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma

Volume 22, Issue 6, June 2021, Pages 1943-1948

Krisna Murti; Neti Neti; Nyiayu Fauziah Kurniawati; Ika Kartika; Riana Sari Puspita Rasyid; Zen Hafy

Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women

Volume 21, Issue 10, October 2020, Pages 3115-3123

Shima Karami; Hedieh Sattarifard; Mohammad Kiumarsi; Sahel Sarabandi; Mohsen Taheri; Mohammad Hashemi; Gholamreza Bahari; Saeid Ghavami

Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression

Volume 20, Issue 11, November 2019, Pages 3421-3427

Aru W Sudoyo; Antonius N Kurniawan; Gita D Kusumo; Teguh P Putra; Fritzie A Rexana; Muhammad Yunus; Akterono D Budiyati; Dicky Kurniawan; Andi Utama; Ahmad R Utomo

Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma

Volume 20, Issue 10, October 2019, Pages 2951-2957

Deepika Chandrasekaran; Sandhya Sundaram; Kadhiresan N; Padmavathi R

Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia

Volume 18, Issue 8, August 2017, Pages 2269-2274

Saeid Taghiloo; Esmaeil Allahmoradi; Reza Ebadi; Mohsen Tehrani; Zahra Hosseini-Khah; Ghasem Janbabai; Ramin Shekarriz; Hossein Asgarian-Omran

Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma

Volume 18, Issue 6, June 2017, Pages 1671-1674

Sakkarn Sangkhamanon; Piangpen Jongpairat; Aumkhae Sookprasert; Kosin Wirasorn; Attapol Titapun; Ake Pugkhem; Piti Ungareevittaya; Jarin Chindaprasirt

Asian Pacific Journal of Cancer Prevention

Journal Archive